CD28 and Alzheimer disease: More recently, the use of larger numbers of surface markers confirmed the significant reduction of naïve CD4+ T cells, identified as CD4+CD28+CD27+CD45RA+CD45RO- in AD patients, compared with age-matched controls and a contemporary increase of CD4+CD28–CD27-CD45RA+CD45RO+ late differentiated memory T cells [75].